Patents for C07F 9 - Compounds containing elements of the 5th group of the periodic system (55,377)
06/2008
06/04/2008CN101193901A Sesamol derivatives or their salts, the process for preparing the same, and the skin external composition containing the same
06/04/2008CN101193868A Pyrimidine derivatives for the treatment of GABA B mediated nervous system disorders
06/04/2008CN101193849A Niobium 2-ethylhexanoate derivative, process for producing the derivative, organic acid metal salt composition containing the derivative, and process for producing thin film from the composition
06/04/2008CN101190927A Method for preparing pivaloyloxymethyl 9-[2-(phosphonylmethoxy)ethyl]adenine
06/04/2008CN101190926A Method for treating glyphosate mother liquid
06/04/2008CN100391962C Method for synthesizing polypren phosphate
06/04/2008CN100391930C 1, 3-propane diol derivatives as bioactive compounds
06/04/2008CN100391917C Process for the separation of mixtures containing m-and p-dichlorobenzene
06/03/2008US7381745 Central nervous system disorders; psychological disorders
06/03/2008US7381537 Use of inhibitors of glutaminyl cyclases for treatment and prevention of disease
06/03/2008CA2284647C Preparation of tertiary phosphines via nickel-catalyzed cross coupling
05/2008
05/29/2008WO2008064274A1 Prodrug salts of 2, 4-pyrimidinediamine compounds and their uses
05/29/2008WO2007071453A8 Organophosphoric derivatives useful as anti-parasitic agents
05/29/2008US20080125605 Novel Phosphorus-Containing Prodrugs
05/29/2008US20080125602 Method For Synthesizing Ionic Complex
05/29/2008US20080125465 Ketone ligands for modulating the expression of exogenous genes via an ecdysone receptor complex
05/29/2008US20080125398 oxidation of 2-{[2-(Diisopropylamino)ethyl]thio}ethyl N,N,N',N'-tetrakis(2-chloroethyl)phosphorodiamidate to 2-{[2-(diisopropylamino)ethyl]sulfonyl}ethyl N,N,N',N'-tetrakis(2-chloroethyl)phosphorodiamidate; salt formation, anticarcinogenic agent
05/29/2008US20080125397 2 (SULFONYL)ETHYL N,N,N',N' tetrakis(2 chloroethyl)phosphorodia
05/29/2008US20080125336 Decreasing catalyst deactivation using lubricant of base oil and additive mixture of an ash-containing phosphorus compound such as a metal dihydrocarbyl dithiophosphate and an ash-free phosphorus compound such as amine salt of acid phosphate; improved phosphorus retention value
05/29/2008CA2673137A1 Prodrug salts of 2,4-pyrimidinediamine compounds and their uses
05/29/2008CA2669104A1 Hydrindane analogs having sphingosine 1-phosphate receptor agonist activity
05/28/2008EP1925622A1 Phosphorus compound, use thereof and flame-retardant polyester fiber
05/28/2008EP1925621A1 Crystalline forms of zoledronic acid
05/28/2008EP1924589A1 Reactions of group 16 elements
05/28/2008EP1924588A1 Chiral phosphoramidites
05/28/2008EP1924587A1 A crystalline form of the zoledronic acid, a process to obtain it and the pharmaceutical composition comprising it
05/28/2008EP1924357A1 Carbonylation method by adding secondary sterically hindered amines
05/28/2008EP1178051B1 Process for selectively producing 1-phosphorylated sugar derivative anomer and process for producing nucleoside
05/28/2008CN101189249A Phosphono-pent-2-en-1-yl nucleosides and analogs
05/28/2008CN101189248A Novel phosphorus-containing thyromimetics
05/28/2008CN101188252A Ester phosphate electrolysis solvent for dye sensitization solar battery
05/28/2008CN101186623A Di(halogenated phenyl)-3-nitrophenyloxyphosphine containing sodium sulphonate and preparation method thereof
05/28/2008CN101186622A Method for preparing solid glyphosate potassium salt
05/28/2008CN101186621A Membrane process production method for soybean high purity liquid phosphatide and powdery phosphatide
05/28/2008CN101186620A Method for preparing phosphate of toluylene compounds containing phenol hydroxyl group
05/28/2008CN100390184C Sodium menadiol diphosphate ester and its pharmaceutical formulation
05/28/2008CN100390183C Antiviral medicine with rare earth of heteropoly compound
05/28/2008CN100390178C Polycycloalkylpurines as adenosine receptor antagonists
05/28/2008CN100390147C Process for the production of heteroaromatic nitriles improved catalyst therefor and a process for the production of said improved catalyst
05/28/2008CN100389731C Adhesive compositions for the hard tissues of the human body
05/27/2008US7378556 Process for making thiophosphine compounds
05/27/2008US7378539 1,4-(2',4'-disubstituted biphenyl) benzenes wherein one biphenyl moiety has an electron withdawing group and the other has an electron donating group, with a switchable bridge between the two; improved molecular electrical rectification; microelectronics
05/27/2008US7378538 Compound having phosphorylcholine group, polymer thereof and process for producing the same
05/27/2008US7378537 selectivity for hexene and octene from ethylene; polymerization inhibition; metal complex of a ligand comprising two diphosphino aminyl moieties linked through a bis(cyclohexylene)methane, where the phosphorus is diphenyl substituted; metal is chromium, titanium or vanadium
05/27/2008US7378445 Treatment of prostate cancer
05/27/2008US7378412 Pharmaceutical compounds
05/27/2008US7378403 phosphoinositol ether lipid analogues and bioisosteres thereof;serine/threonine kinase (protein kinase B (PKB)) inhibitor; antitumor and anticarcinogenic agent; decreasing phosphorylation, increasing apoptosis in a tumor cell, and inhibiting pleckstrin homology (PH) domain binding
05/27/2008US7378194 Materials useful as electrolytic solutes
05/27/2008US7378034 Acidity and dissociation; stability, for doping polymers, as electrolytes in batteries
05/22/2008WO2008061087A1 Polymer fiber containing flame retardant, process for producing the same, and material containing such fibers
05/22/2008WO2008061075A1 Polymer composition containing flame retardant and process for producing the same
05/22/2008WO2008060609A1 Crystalline forms of ibandronate sodium
05/22/2008WO2008060353A1 Polyfluoroether-based phosphates
05/22/2008WO2008060352A1 Fluoroalkyl phosphate compositions
05/22/2008WO2008058722A1 Reagent and use thereof for the production of bisphosphonates
05/22/2008WO2008035367A3 Process for the synthesis of ibandronate sodium
05/22/2008US20080119649 Halocombstatins and methods of synthesis thereof
05/22/2008US20080119442 as hypoxia-selective drugs and radiosensitizers for cancer therapy; nitroreductase inhibitor; 1-(Chloromethyl)-5,6-dinitro-3-(5,6,7-trimethoxyindol-2-carbonyl)-1,2-dihydro-3H-benzo[e]indole; halogenation of naphthalene derivative followed by hydration and cyclization
05/22/2008US20080119441 conditions with inhibited renal phosphate excretion, such as diabetes mellitus, hemodialysis with the progression of diabetic nephropathy, renal failure; [5-(4-Ethylbenzyl)-2-hydroxyphenyl]phosphonic acid; serum phosphate concentration-lowering activity; calcification inhibitor
05/22/2008US20080118817 Additive of electrode for fuel cell, electrode for fuel cell including the same, manufacturing method thereof, and fuel cell using the same
05/22/2008CA2669405A1 Polymer composition containing flame retardant and process for producing the same
05/22/2008CA2669149A1 Polymer fiber containing flame retardant, process for producing the same, and material containing such fibers
05/22/2008CA2666209A1 Polyfluoroether-based phosphates
05/22/2008CA2665837A1 Fluoroalkyl phosphate compositions
05/21/2008EP1923395A1 Use of supplemental promoter in conjuction with a carbon-supported, noble-metal-containing catalyst in liquid phase oxidation reactions
05/21/2008EP1923394A1 Reagent and use thereof for the production of bisphosphonates
05/21/2008EP1923052A1 Novel polymorphs and pseudopolymorphs of risedronate sodium
05/21/2008EP1922389A1 Absorbent composition containing molecules with a hindered amine and a metal sulfonate, phosphonate or carboxylate structure for acid gas scrubbing process
05/21/2008EP1922326A1 Biomarkers useful for diagnosing prostate cancer, and methods thereof
05/21/2008EP1922325A1 Methods for the diagnosis of dementia and other neurological disorders
05/21/2008EP1191029B1 Process for the preparation of condensed phosphoric esters
05/21/2008EP0781138B1 Lipid analogs for treating viral infections
05/21/2008DE102006053177A1 Neues Verfahren zur Herstellung von organischen Phosphorverbindungen, mit diesem Verfahren hergestellte Phosphorverbindungen, deren Metallkomplexe und Verwendung New process for preparing organic phosphorus compounds, phosphorus compounds produced by this method, and their metal complexes using
05/21/2008CN101184768A Low-viscosity ionic liquids
05/21/2008CN101184494A Method for preparing and separating phospholipids
05/21/2008CN101182339A Metal-imino complexes suitable for use as vapor deposition precursors
05/21/2008CN101182331A Adefovir dipivoxil ester colalin derivatives as well as preparation method and uses thereof
05/21/2008CN101182330A Method for preparing pentaerythrite bisphosphite anti-oxidant
05/21/2008CN101181277A Nucleotide analog composition and synthesis method
05/21/2008CN100389118C C2-symmetrical bis ruthenium Diphosphine Ligand only with surface chirality
05/21/2008CN100389116C Method for producing glyphosate monovalent salt using glyphosate bivalent, trivalent salt
05/20/2008US7375244 efficiently catalyzes an enantio selective asymmetric nucleophilic addition reaction of an alpha -iminophosphonic acid ester
05/20/2008US7375241 use of the metal complexes as catalysts for enantioselective addition reactions with prochiral organic compounds
05/20/2008US7375217 Reduction of the benzoquinone moiety to form a hydroquinone, and salt formation, producing 17-ammonium hydroquinone ansamycin analogs with improved solubility and air stability; antiproliferative and anticarcinogenic agents
05/20/2008US7375133 Pharmaceutical compositions including carotenoid ether analogs or derivatives for the inhibition and amelioration of disease
05/20/2008US7375121 Chemical compounds
05/20/2008US7375093 Nuclear receptor-based inducible gene expression system
05/20/2008US7374900 Fluorescent substrates for detecting organophosphatase enzyme activity
05/20/2008US7374882 Method for base sequencing and biologically active nucleic acids
05/20/2008US7374824 Core-shell nanocrystallite comprising tellurium-containing nanocrystalline core and semiconductor shell
05/20/2008US7374746 diagnostic detection of diseases accompanied with an abnormality of calcium hydroxyapatite using in vivo imaging; contrast agent comprising a fluorescent moiety covalently linked to a bisphosphonate moiety such as, alendronate, clodronate, EB-1053, etidronate, ibandronate, incadronate, neridronate
05/20/2008CA2466780C Preparation of ionic liquids
05/20/2008CA2231971C Hypolipidemic 1,4-benzothiazepine-1,1-dioxides
05/20/2008CA2223510C Synthetic catalytic free radical scavengers useful as antioxidants for prevention and therapy of disease
05/20/2008CA2159610C Prodrugs with enhanced penetration into cells
05/15/2008WO2008056264A2 Novel nucleotide analogues as percursor molecules for antivirals
05/15/2008WO2008056129A1 Process for the preparation of biphosphonic acids and salts thereof
05/15/2008WO2008055997A1 Use of tri-substituted glycerol compounds for the treatment of radiation injuries
05/15/2008WO2008055964A1 Method for producing cyclic phosphines or biphosphines, cyclic phosphonates of optically active diols, and the production of same
05/15/2008WO2008055963A1 Novel method for producing organic phosphorus compounds, phosphorus compounds produced using said method, the metal complexes of said compounds, and use of same